Intrinsic Value of S&P & Nasdaq Contact Us

Geron Corporation GERN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
55/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.89
+248.5%

Geron Corporation (GERN) — Analyst outlook / Analyst consensus target is. Based on 22 analyst ratings, the consensus is bullish — 17 Buy, 5 Hold.

The consensus price target is $5.89 (low: $4.00, high: $8.00), representing an upside of 248.5% from the current price $1.69.

Analysts estimate Earnings Per Share (EPS) of $-0.25 and revenue of $0.09B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-0.27 vs est $-0.25 (missed -7%). 2025: actual $-0.13 vs est $-0.10 (missed -30%). Analyst accuracy: 85%.

GERN Stock — 12-Month Price Forecast

$5.89
▲ +248.52% Upside
Average Price Target
Based on 22 Wall Street analysts offering 12-month price targets for Geron Corporation, the average price target is $5.89, with a high forecast of $8.00, and a low forecast of $4.00.
The average price target represents a +248.52% change from the last price of $1.69.
Highest Price Target
$8.00
Average Price Target
$5.89
Lowest Price Target
$4.00

GERN Analyst Ratings

Buy
22
Ratings
17 Buy
5 Hold
Based on 22 analysts giving stock ratings to Geron Corporation in the past 3 months
Rating breakdown
Buy
17 77%
Hold
5 23%
77%
Buy
17 analysts
23%
Hold
5 analysts
0%
Sell
0 analysts

EPS Estimates — GERN

85%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$0.27 vs Est –$0.25 ▼ 6.5% off
2025 Actual –$0.13 vs Est –$0.10 ▼ 23.1% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — GERN

90%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.077B vs Est $0.091B ▼ 18.4% off
2025 Actual $0.184B vs Est $0.186B ▼ 1.3% off
Revenue Trend
Strong revenue growth over the period shown. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message